1. Home
  2. ITRM vs CFFN Comparison

ITRM vs CFFN Comparison

Compare ITRM & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • CFFN
  • Stock Information
  • Founded
  • ITRM 2015
  • CFFN 1893
  • Country
  • ITRM Ireland
  • CFFN United States
  • Employees
  • ITRM N/A
  • CFFN N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • CFFN Savings Institutions
  • Sector
  • ITRM Health Care
  • CFFN Finance
  • Exchange
  • ITRM Nasdaq
  • CFFN Nasdaq
  • Market Cap
  • ITRM 37.7M
  • CFFN 680.7M
  • IPO Year
  • ITRM 2018
  • CFFN 1999
  • Fundamental
  • Price
  • ITRM $1.32
  • CFFN $5.69
  • Analyst Decision
  • ITRM Strong Buy
  • CFFN Hold
  • Analyst Count
  • ITRM 1
  • CFFN 2
  • Target Price
  • ITRM $5.00
  • CFFN $6.50
  • AVG Volume (30 Days)
  • ITRM 373.9K
  • CFFN 938.8K
  • Earning Date
  • ITRM 05-12-2025
  • CFFN 04-23-2025
  • Dividend Yield
  • ITRM N/A
  • CFFN 5.99%
  • EPS Growth
  • ITRM N/A
  • CFFN N/A
  • EPS
  • ITRM N/A
  • CFFN 0.41
  • Revenue
  • ITRM N/A
  • CFFN $184,847,000.00
  • Revenue This Year
  • ITRM N/A
  • CFFN $7.19
  • Revenue Next Year
  • ITRM $150.10
  • CFFN $9.50
  • P/E Ratio
  • ITRM N/A
  • CFFN $13.84
  • Revenue Growth
  • ITRM N/A
  • CFFN N/A
  • 52 Week Low
  • ITRM $0.81
  • CFFN $4.76
  • 52 Week High
  • ITRM $3.02
  • CFFN $7.20
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 56.35
  • CFFN 58.75
  • Support Level
  • ITRM $1.01
  • CFFN $5.10
  • Resistance Level
  • ITRM $1.42
  • CFFN $5.30
  • Average True Range (ATR)
  • ITRM 0.09
  • CFFN 0.26
  • MACD
  • ITRM 0.03
  • CFFN 0.05
  • Stochastic Oscillator
  • ITRM 73.17
  • CFFN 91.33

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

Share on Social Networks: